Sat, November 5, 2011
[ Sat, Nov 05th 2011 ]: Market Wire
Savient Pharmaceuticals Announces New Data Surrou .. t of Refractory Chronic Gout at the American Coll
[ Sat, Nov 05th 2011 ]: Market Wire
Tenet Announces Upsizing and Pricing of Its Private Offering of Senior Secured Notes due 2018
[ Sat, Nov 05th 2011 ]: Market Wire
Teleflex to Focus on Innovative Products and Solu .. American Association of Respiratory Care Congress
[ Sat, Nov 05th 2011 ]: Market Wire
Kinetic Concepts, Inc. Gives Notice of Make-Whole .. rs of Its 3.25% Convertible Senior Notes due 2015
[ Sat, Nov 05th 2011 ]: Market Wire
Kinetic Concepts, Inc. Completes Merger with Apax Consortium
[ Sat, Nov 05th 2011 ]: Market Wire
CareFusion Announces New Ventilation Solution to .. ls Provide Improved Patient Care and Reduce Costs
[ Sat, Nov 05th 2011 ]: Market Wire
Health Net Wins Two Awards in 2011 National Health Information Awards Program
[ Sat, Nov 05th 2011 ]: Market Wire
BioMimetic Therapeutics, Inc. to Report 2011 Third Quarter Financial Results on November 8
[ Sat, Nov 05th 2011 ]: Market Wire
Interim Data for Merck's VICTRELISTM (boceprevir) .. ents with Chronic Hepatitis C Genotype 1 to be Pr
[ Sat, Nov 05th 2011 ]: Market Wire
Gilead Announces Positive Five-Year Data Showing .. rosis and Cirrhosis Caused by Chronic Hepatitis B
[ Sat, Nov 05th 2011 ]: Market Wire
Interim Data for Merck';;s VICTREL .. ll Responder Patients with Chronic Hepatitis C Ge
[ Sat, Nov 05th 2011 ]: Market Wire
Interim Data for Merck';;;s VIC .. or Null Responder Patients with Chronic Hepatitis
[ Sat, Nov 05th 2011 ]: Market Wire
Interim Data for Merck';;;;s .. Prior Null Responder Patients with Chronic Hepati
[ Sat, Nov 05th 2011 ]: Market Wire
Medtronicas Unmatched Portfolio of Cardiovascular .. ices Features Prominently on Program for TCT 2011
[ Sat, Nov 05th 2011 ]: Market Wire
Bull & Lifshitz, LLP Announces Investigation of Adolor Corporation
Fri, November 4, 2011
[ Fri, Nov 04th 2011 ]: Market Wire
iBio, Inc. Receives Notice from NYSE Amex Staff t .. ntly is Below Certain Continued Listing Standards
[ Fri, Nov 04th 2011 ]: Market Wire
CML HealthCare Inc. Announces Release Date for 2011 Third Quarter Financial Results
[ Fri, Nov 04th 2011 ]: Market Wire
URBAN AG Names Billy V. Ray Jr. President and Member of Board of Directors
[ Fri, Nov 04th 2011 ]: Market Wire
CML HealthCare Inc. Celebrates Medical Radiation Technologists Week-November 6-12, 2011
[ Fri, Nov 04th 2011 ]: Market Wire
KCI e consrcio dirigidos pela Apax Partners anunciam concluso das conversaes sobre gesto executiva
[ Fri, Nov 04th 2011 ]: Market Wire
Acorda Therapeutics Reports Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ]: Market Wire
Santarus and Pharming Announce Presentation of Re .. Analyses of Data from Clinical Studies of RHUCIN
[ Fri, Nov 04th 2011 ]: Market Wire
Ardea Biosciences Reports Recent Accomplishments, .. g Events and Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ]: Market Wire
Cancer Treatments From Dendreon and Cell Therapeutics May Not Be as Lucrative as Hoped
[ Fri, Nov 04th 2011 ]: Market Wire
Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as Expected
[ Fri, Nov 04th 2011 ]: Market Wire
Equity Research on Raptor Pharmaceuticals Corp. a .. Mixed Results for Diagnostic Substances Industry
[ Fri, Nov 04th 2011 ]: Market Wire
For The Earth Corporation Grows Globally
[ Fri, Nov 04th 2011 ]: Market Wire
Novadaq Reports Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ]: Market Wire
Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
[ Fri, Nov 04th 2011 ]: Market Wire
Quest Diagnostics anuncia el lanzamiento del test .. Direct para gripe y virus respiratorios en Europa
Thu, November 3, 2011
[ Thu, Nov 03rd 2011 ]: Market Wire
Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China
[ Thu, Nov 03rd 2011 ]: Market Wire
Humana Inc. to Present at the Credit Suisse 2011 Healthcare Conference
[ Thu, Nov 03rd 2011 ]: Market Wire
Sirona Biochem Announces New Grant of Stock Options
[ Thu, Nov 03rd 2011 ]: Market Wire
MSA Declares Fourth Quarter Dividend
[ Thu, Nov 03rd 2011 ]: Market Wire
Threshold Pharmaceuticals Reports Third Quarter 2011 Financial and Operational Results
[ Thu, Nov 03rd 2011 ]: Market Wire
AVI BioPharma Announces Third Quarter 2011 Financial Results and Recent Corporate Developments
[ Thu, Nov 03rd 2011 ]: Market Wire
SpectraScience to Hold Business Update Conference Call on November 10, 2011
[ Thu, Nov 03rd 2011 ]: Market Wire
BioElectronics' Study on Postoperative Pain Reduc .. ublished in the Aesthetic Plastic Surgery Journal
[ Thu, Nov 03rd 2011 ]: Market Wire
MethylGene Reports Third Quarter 2011 Financial Results and Provides Clinical Update
[ Thu, Nov 03rd 2011 ]: Market Wire
Dynavax Prices Public Offering of Common Stock
[ Thu, Nov 03rd 2011 ]: Market Wire
SecureAlert, Inc. and Commonwealth of Puerto Rico .. Violence With Focus on Family Safety and Real-Tim
[ Thu, Nov 03rd 2011 ]: Market Wire
Celsion Corporation to Hold Third Quarter 2011 Fi .. ts Conference Call on Thursday, November 10, 2011
[ Thu, Nov 03rd 2011 ]: Market Wire
FONAR Reports Error in Reports Regarding Its Common Stock
[ Thu, Nov 03rd 2011 ]: Market Wire
Medivation and Astellas Announce Positive Surviva .. of Phase 3 AFFIRM Trial of MDV3100 in Men With Ad
[ Thu, Nov 03rd 2011 ]: Market Wire
Kraig Biocraft Laboratories, Inc. Signs Spider Si .. cense Agreement With the University of Notre Dame
Wed, November 2, 2011
[ Wed, Nov 02nd 2011 ]: Market Wire
ING 3Q11 underlying net profit increases to EUR 1,285 million
[ Wed, Nov 02nd 2011 ]: Market Wire
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
[ Wed, Nov 02nd 2011 ]: Market Wire
Dynavax Announces Proposed Public Offering of Common Stock
[ Wed, Nov 02nd 2011 ]: Market Wire
Stellar Biotechnologies to Submit Documents for Registration of Shares in the U.S.
[ Wed, Nov 02nd 2011 ]: Market Wire
BIOLASE to Present at WJB Capital Group's Laser Company -- Management Access Event
[ Wed, Nov 02nd 2011 ]: Market Wire
NuPathe Appoints Bart J. Dunn as Vice President, Corporate Development &;; Licensing
[ Wed, Nov 02nd 2011 ]: Market Wire
ProPhase Labs to Release Third Quarter Results on Wednesday, November 9th
[ Wed, Nov 02nd 2011 ]: Market Wire
Faster FDA Drug Reviews Should Benefit Cardium Therapeutics and CytRx Corporation
[ Wed, Nov 02nd 2011 ]: Market Wire
Faster FDA Review Process Bodes Well for NPS Pharmaceuticals and Cel-Sci Corp
[ Wed, Nov 02nd 2011 ]: Market Wire
IBEX Reports Q4 and Fiscal 2011 Results
[ Wed, Nov 02nd 2011 ]: Market Wire
New Studies Show GERD Is Best Assessed Off PPI Therapy
[ Wed, Nov 02nd 2011 ]: Market Wire
MELA Sciences Announces FDA Approval for MelaFind(R)
[ Wed, Nov 02nd 2011 ]: Market Wire
Medivation Announces Third Quarter Financial Resu .. ts Teleconference and Webcast on November 9, 2011
[ Wed, Nov 02nd 2011 ]: Market Wire
Implant Sciences Signs Cooperative Research && .. nt With TSL S&;;T, a Directorate of the
[ Wed, Nov 02nd 2011 ]: Market Wire
Threshold Pharmaceuticals Appoints Nipun Davar as .. t of Pharmaceutical Development and Manufacturing
Tue, November 1, 2011
[ Tue, Nov 01st 2011 ]: Market Wire
Solta and Medicis Announce Close of Agreement for LIPOSONIX
[ Tue, Nov 01st 2011 ]: Market Wire
ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results
[ Tue, Nov 01st 2011 ]: Market Wire
Critical Outcome Technologies Inc. to Deliver Pod .. on on COTI-2 at Influential Scientific Conference
[ Tue, Nov 01st 2011 ]: Market Wire
Syneron Sets New Facial Rejuvenation Standard Wit .. t the American Society of Dermatologic Surgery Co
[ Tue, Nov 01st 2011 ]: Market Wire
Immunovaccine to Report Q3 2011 Financial Results and Conference Call
[ Tue, Nov 01st 2011 ]: Market Wire
RepliCel Provides Update on First-in-man Clinical Trials and Recent Corporate Activity
[ Tue, Nov 01st 2011 ]: Market Wire
Equity Research on Pharmaceutical Product Develop .. cs Inc. - Acquisitions and Privatizations Dominat
[ Tue, Nov 01st 2011 ]: Market Wire
Aeolus Pharmaceuticals Announces Positive Results .. Neupogen(R) as Combination Therapy for Treatment
[ Tue, Nov 01st 2011 ]: Market Wire
Cytokinetics Announces Initiation of Second Cohor .. l Trial Evaluating CK-2017357 in Patients With AL
[ Tue, Nov 01st 2011 ]: Market Wire
VentriPoint Commences Clinical Studies of Pulmona .. ension Application of Right Heart Analysis System
[ Tue, Nov 01st 2011 ]: Market Wire
Imaging3, Inc. FDA 510(k) Protocol Meeting Update
[ Tue, Nov 01st 2011 ]: Market Wire
SciClone Pharmaceuticals to Report Third Quarter 2011 Financial Results on November 8
[ Tue, Nov 01st 2011 ]: Market Wire
Implant Sciences' Explosives Trace Detector Deployed at Middle East Embassy
[ Tue, Nov 01st 2011 ]: Market Wire
Reflect Scientific, Inc. Strengthens Liquid Nitrogen Cooling Intellectual Property Position
[ Tue, Nov 01st 2011 ]: Market Wire
Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference
Mon, October 31, 2011
[ Mon, Oct 31st 2011 ]: Market Wire
Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
[ Mon, Oct 31st 2011 ]: Market Wire
Exelixis to Initiate Cabozantinib a306 Trial with Pain Endpoint in mCRPC
[ Mon, Oct 31st 2011 ]: Market Wire
SRI/Surgical Express Third Quarter 2011 Conference Call
[ Mon, Oct 31st 2011 ]: Market Wire
Merck Announces Dates for R&D and Business Briefi .. and Fourth-Quarter 2011 Sales and Earnings Report
[ Mon, Oct 31st 2011 ]: Market Wire
NPS Pharmaceuticals to Host Conference Call to Di .. can College of Gastroenterology Annual Scientific
[ Mon, Oct 31st 2011 ]: Market Wire
Medtronic Receives First FDA Approval of Cobalt C .. Expandable Stent to Treat Narrowed Iliac Arteries
[ Mon, Oct 31st 2011 ]: Market Wire
PharmStar to Pursue SEC Fully-Reporting Status
[ Mon, Oct 31st 2011 ]: Market Wire
Teva Presents New Data on QNASLa" at the 2011 Ame .. of Allergy, Asthma and Immunology Annual Meeting
[ Mon, Oct 31st 2011 ]: Market Wire
CytRx Announces Favorable Initial Results from it .. nical Trial in Patients with Soft Tissue Sarcomas
[ Mon, Oct 31st 2011 ]: Market Wire
Health Net Named to USO-Metroas Circle of Stars
[ Mon, Oct 31st 2011 ]: Market Wire
Trimel Initiates Dosing in Phase III Trial of CompleoTRT in Male Hypogonadal Patients
[ Mon, Oct 31st 2011 ]: Market Wire
Given Imaging Announces New Studies Validate Use .. llCam SB(R) to Detect and Monitor Crohn's Disease
[ Mon, Oct 31st 2011 ]: Market Wire
Teleflex Launches New Website for Teleflex ISIS HVTa", the First Comprehensive Endotracheal Tube
[ Mon, Oct 31st 2011 ]: Market Wire
Illumina Names Dr. Daniel S. Grosu Chief Medical Officer
[ Mon, Oct 31st 2011 ]: Market Wire
Winner Medical Ranked High by CNTAC
Sat, October 29, 2011
[ Sat, Oct 29th 2011 ]: Market Wire
Gilead presenta solicitud de nuevo frmaco a la FD .. "Quad" de nica pastilla una vez al da para el VIH
Fri, October 28, 2011
[ Fri, Oct 28th 2011 ]: Market Wire
Almost Family, Inc. to Report Third Quarter 2011 Financial Results on November 2, 2011
[ Fri, Oct 28th 2011 ]: Market Wire
Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
[ Fri, Oct 28th 2011 ]: Market Wire
Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company
[ Fri, Oct 28th 2011 ]: Market Wire
Ergoresearch Ltd Reports Growing Sales of 9.0% fo .. 30, 2011. Earnings Before Tax for the Period Amou
[ Fri, Oct 28th 2011 ]: Market Wire
Medtronic Receives IDE Approval to Conduct ASPIRE .. sulin Pump with Low Glucose Suspend for US Market
[ Fri, Oct 28th 2011 ]: Market Wire
Advaxis Receives Additional Financing
[ Fri, Oct 28th 2011 ]: Market Wire
The Medicines Company and Daiichi Sankyo Announce Angiox(R) (Bivalirudin) Co-Promotion for Germany
[ Fri, Oct 28th 2011 ]: Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. Mylan Inc. and Medicis Pharmaceutical Corporation
[ Fri, Oct 28th 2011 ]: Market Wire
Egan-Jones Recommends Poniard Shareholders Vote " .. osed Merger With ALLOZYNE and Reverse Stock Split
[ Fri, Oct 28th 2011 ]: Market Wire
Analyst Research on Sequenom Inc. and Life Techno .. Companies Succeeding in Bringing Products to the
[ Fri, Oct 28th 2011 ]: Market Wire
Pfizer Completes Acquisition Of Icagen
[ Fri, Oct 28th 2011 ]: Market Wire
Gilead deposita una domanda di approvazione di nu .. per gli Alimenti e i Medicinali statunitense (Foo
[ Fri, Oct 28th 2011 ]: Market Wire
Salix Pharmaceuticals Previews American College of Gastroenterology 2011
[ Fri, Oct 28th 2011 ]: Market Wire
Gilead stellt Zulassungsantrag bei der FDA fr neu .. r HIV-Therapie mit tglich einer einzigen Tablette
[ Fri, Oct 28th 2011 ]: Market Wire
Threshold Pharmaceuticals Reports Further Promising Data With TH-302 in Soft Tissue Sarcoma
Thu, October 27, 2011
[ Thu, Oct 27th 2011 ]: Market Wire
Unity Powers Army OneSource Virtual World
[ Thu, Oct 27th 2011 ]: Market Wire
Crystal Research Associates, LLC Issues Executive .. al Overview (EIO) on Adamis Pharmaceuticals Corp.
[ Thu, Oct 27th 2011 ]: Market Wire
FMX Ventures Inc. and Tolima Gold Corp. Announce .. or and Commencement of Private Placement Offering
[ Thu, Oct 27th 2011 ]: Market Wire
Cannabis Science Releases First Cannabis-Extract- .. Now at Cannabis Therapeutics, 957 E. Fillmore St,
[ Thu, Oct 27th 2011 ]: Market Wire
Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific
[ Thu, Oct 27th 2011 ]: Market Wire
Biogen Idec et Portola Pharmaceuticals annoncent .. ns le cadre daun programme dainhibiteur oral de l
[ Thu, Oct 27th 2011 ]: Market Wire
Biogen Idec und Portola Pharmaceuticals verknden .. rogramm fr den oral verabreichten SYK-Inhibitor b
[ Thu, Oct 27th 2011 ]: Market Wire
Health Net Federal Services Launches Mobile Site .. he-Go Access to Health Care for Military Families
[ Thu, Oct 27th 2011 ]: Market Wire
Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector
[ Thu, Oct 27th 2011 ]: Market Wire
PharmaGap Sets Time for in Vivo Tests
[ Thu, Oct 27th 2011 ]: Market Wire
Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)
[ Thu, Oct 27th 2011 ]: Market Wire
Implant Sciences Explosives Detection Technology Protects Major European Bank
[ Thu, Oct 27th 2011 ]: Market Wire
Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011
[ Thu, Oct 27th 2011 ]: Market Wire
ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
[ Thu, Oct 27th 2011 ]: Market Wire
Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu
Wed, October 26, 2011
[ Wed, Oct 26th 2011 ]: Market Wire
Medtronic Starts Landmark Study of Hypertension Treatment
[ Wed, Oct 26th 2011 ]: Market Wire
Biogen Idec oglasza pozytywne podsumowanie wynikw .. 3. badan nad doustnym BG-12 u pacjentw ze stward
[ Wed, Oct 26th 2011 ]: Market Wire
Stellar Biotechnologies &;; Life Diagno .. e Agreement for Stellar Brand KLH ELISA Test Kits
[ Wed, Oct 26th 2011 ]: Market Wire
2011 Third Quarter and Nine-Month Results
[ Wed, Oct 26th 2011 ]: Market Wire
Seattle Genetics Appoints Vice President, Medical .. nces Vice President, Quality Management Promotion
[ Wed, Oct 26th 2011 ]: Market Wire
Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials
[ Wed, Oct 26th 2011 ]: Market Wire
Cytori to Webcast Third Quarter Financial Results November 3
[ Wed, Oct 26th 2011 ]: Market Wire
Magellan Health Services Joins with Share Our Strength to End Childhood Hunger in America
[ Wed, Oct 26th 2011 ]: Market Wire
Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012
[ Wed, Oct 26th 2011 ]: Market Wire
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
[ Wed, Oct 26th 2011 ]: Market Wire
Covidien Launches Worldas First Non-Absorbable, Uni-Directional Knotless Suture
[ Wed, Oct 26th 2011 ]: Market Wire
Biogen Idec annonce des rsultats trs positifs l'i .. se 3 tudiant BG-12 (dimthylfumarate) administr pa
[ Wed, Oct 26th 2011 ]: Market Wire
Biogen Idec annuncia risultati preliminari positi .. ico di fase III del farmaco orale BG-12 (dimetilf
[ Wed, Oct 26th 2011 ]: Market Wire
Biogen Idec Announces Positive Top-Line Results f .. stigating Oral BG-12 (Dimethyl Fumarate) in Multi
[ Wed, Oct 26th 2011 ]: Market Wire
Biogen Idec meldet positive Topline-Ergebnisse au .. zur Prfung von oral verabreichtem BG-12 (Dimethyl
Tue, October 25, 2011
[ Tue, Oct 25th 2011 ]: Market Wire
West to Host 2011 Third Quarter Conference Call
[ Tue, Oct 25th 2011 ]: Market Wire
USANA Health Sciences Reports Third Quarter 2011 Financial Results
[ Tue, Oct 25th 2011 ]: Market Wire
Micro Imaging Technology Receives a Substantial Exclusive Licensing Proposal From EPIC Corporation
[ Tue, Oct 25th 2011 ]: Market Wire
Daniel Levangie Appointed to Insulet's Board of Directors
[ Tue, Oct 25th 2011 ]: Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in K-V Pharmaceutical Company o
[ Tue, Oct 25th 2011 ]: Market Wire
VistaGen Therapeutics Reports Identification of C .. ts High-Yield Purification of Human Pluripotent S
[ Tue, Oct 25th 2011 ]: Market Wire
Amarantus BioSciences Appoints Dr. Owen Garrick as Strategic Advisor
[ Tue, Oct 25th 2011 ]: Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. earch on Thoratec Corporation and C.R. Bard, Inc.
[ Tue, Oct 25th 2011 ]: Market Wire
Daxor Announces Filing of Patents for Total Body Albumin Analyzer
[ Tue, Oct 25th 2011 ]: Market Wire
OmniGuide Appoints Scott Flora as President & CEO
[ Tue, Oct 25th 2011 ]: Market Wire
ZYTO Corp Appoints Leading Experts to Scientific Advisory Board
[ Tue, Oct 25th 2011 ]: Market Wire
Implant Sciences Sells Follow-On Order to China's Beijing Subway System
[ Tue, Oct 25th 2011 ]: Market Wire
Gilead e GlobeImmune annunciano un contratto di l .. o sviluppo di vaccini terapeutici per il trattame
[ Tue, Oct 25th 2011 ]: Market Wire
Exelixis Appoints Executive Vice President and Chief Commercial Officer
[ Tue, Oct 25th 2011 ]: Market Wire
DaVita Announces Government Inquiry
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ]: Market Wire
Blinded Results From Low Dose Cohort of Phase II SHIGATEC Trial Presented at IDSA Annual Meeting
[ Mon, Oct 24th 2011 ]: Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Adolor Corporation
[ Mon, Oct 24th 2011 ]: Market Wire
Harwood Feffer LLP Announces Investigation of HealthSpring Inc.
[ Mon, Oct 24th 2011 ]: Market Wire
Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom
[ Mon, Oct 24th 2011 ]: Market Wire
Diligent Boardbooks Announces Fifth Consecutive R .. r, Boardbooks Now Used by 62 TSX Listed Companies
[ Mon, Oct 24th 2011 ]: Market Wire
Syneron Medical to Report Third Quarter 2011 Financial Results on November 10, 2011
[ Mon, Oct 24th 2011 ]: Market Wire
Growing Safety Concerns Weigh on Medical Equipment and Supplies Sector
[ Mon, Oct 24th 2011 ]: Market Wire
NPS Pharmaceuticals Reports Upcoming Presentation .. ege of Gastroenterology Annual Scientific Meeting
[ Mon, Oct 24th 2011 ]: Market Wire
Cigna to Acquire HealthSpring
[ Mon, Oct 24th 2011 ]: Market Wire
PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials
[ Mon, Oct 24th 2011 ]: Market Wire
Research on GlaxoSmithKline plc and Merck &;; Co. Inc. -- Big Pharma Stable for Now
[ Mon, Oct 24th 2011 ]: Market Wire
SecureAlert, Inc. Achieves Milestone of Deploymen .. Units of Its Newest ReliAlert(TM) GPS Tracking a
[ Mon, Oct 24th 2011 ]: Market Wire
Aeolus Pharmaceuticals Announces NIH Counteract G .. 10150 as a Treatment Against Nerve Agent Exposure
[ Mon, Oct 24th 2011 ]: Market Wire
Novadaq to Release Q3-2011 Financial Results on November 4-Conference Call to Follow
[ Mon, Oct 24th 2011 ]: Market Wire
Waters Recognizes the Dr. Ganesh Anand Laboratory .. l University of Singapore as Center of Innovation
Sat, October 22, 2011
[ Sat, Oct 22nd 2011 ]: Market Wire
Biogen Idec und Abbott prsentieren positive Daten .. ase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kon
[ Sat, Oct 22nd 2011 ]: Market Wire
Zimmer presenta il sistema a vite pedicolare Path .. minimamente invasivo destinato al mercato europeo
[ Sat, Oct 22nd 2011 ]: Market Wire
Biogen Idec en Abbott presenteren positieve resul .. P uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS
[ Sat, Oct 22nd 2011 ]: Market Wire
Biogen Idec et Abbott pr©sentent les r©sultats .. phase 2b pour le Daclizumab HYP lors du congrs EC
Fri, October 21, 2011
[ Fri, Oct 21st 2011 ]: Market Wire
Kahn Swick &;; Foti, LLC and Former Lou .. nce Securities Class Action Lawsuit Against K-V P
[ Fri, Oct 21st 2011 ]: Market Wire
Data From Phase 2 Clinical Studies of Telotristat .. rcinoid Syndrome to be Presented at North America
[ Fri, Oct 21st 2011 ]: Market Wire
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
[ Fri, Oct 21st 2011 ]: Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against K-V Pharmaceutical Comp
[ Fri, Oct 21st 2011 ]: Market Wire
AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger
[ Fri, Oct 21st 2011 ]: Market Wire
Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance
[ Fri, Oct 21st 2011 ]: Market Wire
Wall Street Reporter, Inc. Interviews Micro Imagi .. echnology, Inc. Chairman and CEO, Michael Brennan
[ Fri, Oct 21st 2011 ]: Market Wire
AVI BioPharma's RNA-Based Therapeutics for Treatm .. ses Show Positive Safety Data in First Five of Si
[ Fri, Oct 21st 2011 ]: Market Wire
For The Earth Corporation Strengthens Its Portfolio With Kat Box King
[ Fri, Oct 21st 2011 ]: Market Wire
GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 21st 2011 ]: Market Wire
Oral BG-12 (Dimetil Fumarato) reduce notablemente .. con esclerosis multiple (MS) y el avance de la d
[ Fri, Oct 21st 2011 ]: Market Wire
Oraal toegediende BG-12 (dimethyl fumaraat) reduc .. lerose en voortschrijding aftakeling in Fase 3 DE
[ Fri, Oct 21st 2011 ]: Market Wire
Acorda Therapeutics Announces Data on AMPYRA® Pr .. h Joint Triennial Congress of ECTRIMS and ACTRIMS
[ Fri, Oct 21st 2011 ]: Market Wire
Reduzierte Schubhufigkeit und Behinderungsprogres .. durch oral verabreichtes BG-12 (Dimethylfumarat):
[ Fri, Oct 21st 2011 ]: Market Wire
Selon les observations de l'essai clinique DEFINE .. -12 (dim©thylfumarate) r©duit de manire signifi
Thu, October 20, 2011
[ Thu, Oct 20th 2011 ]: Market Wire
Oral BG-12 (dimetilefumarato) riduce in modo sign .. clerosi multipla (SM) e l'avanzamento della disab
[ Thu, Oct 20th 2011 ]: Market Wire
Helix BioPharma Corp. Terminates Agreement With ACM Alpha Consulting Management Est.
[ Thu, Oct 20th 2011 ]: Market Wire
Biogen Idec y Elan reciben notificacin de ampliacin de la fecha PDUFA
[ Thu, Oct 20th 2011 ]: Market Wire
Amarantus BioSciences Receives Notice of Allowance for U.S. Patent Covering MANF Discovery
[ Thu, Oct 20th 2011 ]: Market Wire
Critical Outcome Technologies Inc. Successfully Completes Critical Study
[ Thu, Oct 20th 2011 ]: Market Wire
Analyst View, Impact of Global Events - Research .. on &;; Johnson and Endo Pharmaceuticals
[ Thu, Oct 20th 2011 ]: Market Wire
Dendreon Announces Webcast Presentations at Upcoming Conferences
[ Thu, Oct 20th 2011 ]: Market Wire
Prorogata la data PDUFA per Biogen Idec ed Elan
[ Thu, Oct 20th 2011 ]: Market Wire
Biogen Idec and Elan Receive Notification of PDUFA Date Extension
[ Thu, Oct 20th 2011 ]: Market Wire
Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference
[ Thu, Oct 20th 2011 ]: Market Wire
Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial
[ Thu, Oct 20th 2011 ]: Market Wire
Unigene Completes All Patient Dosing in Phase 2 S .. Treatment of Osteoporosis in Postmenopausal Women
[ Thu, Oct 20th 2011 ]: Market Wire
Interim Phase IIb Data for Merck's VICTRELISa" (b .. cted with Chronic Hepatitis C and HIV-1 Presented
[ Thu, Oct 20th 2011 ]: Market Wire
Cubist to Feature Antibiotic Development Programs at 49th IDSA
[ Thu, Oct 20th 2011 ]: Market Wire
Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial

DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call


  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. third-quarter-2011-earnings-conference-call.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference... -- CUPERTINO, Calif., Oct. 26, 2011 /PRNewswire/ --

DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call

[ ]
[ ]

[ Download image ]

CUPERTINO, Calif., Oct. 26, 2011 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: [ DRRX ]) third quarter 2011 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, November 3, 2011 at 4:30 pm Eastern Time (1:30 pm Pacific Time).

(Logo:  [ http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ])

A live audio webcast of the presentation will be available by accessing DURECT's homepage at [ http://www.durect.com ] and clicking "Investor Relations."  If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit [ www.durect.com ].

NOTE: POSIDUR™, SABER™, ORADUR®, TRANSDUR®, and ELADUR® are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.

SOURCE DURECT Corporation

[ Back to top ]

RELATED LINKS
[ http://www.durect.com ]


Publication Contributing Sources